Steven Cohen Sight Sciences, Inc. Transaction History

Point72 Asset Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.02 - $5.89 $38,989 - $57,127	9,699 Added 5.03%	202,700 $1.07 Million
Q4 2023 Feb 14, 2024	BUY	$1.29 - $5.86 $51,730 - $234,991	40,101 Added 26.23%	193,001 $995,000
Q3 2023 Nov 14, 2023	BUY	$2.88 - $8.8 $440,317 - $1.35 Million	152,888 Added 1274066.62%	152,900 $515,000
Q2 2023 Aug 14, 2023	SELL	$7.46 - $10.67 $46,528 - $66,548	-6,237 Reduced 99.81%	12 $0
Q1 2023 May 15, 2023	BUY	$8.44 - $13.35 $52,741 - $83,424	6,249 New	6,249 $54,000
Q3 2022 Nov 14, 2022	BUY	$6.1 - $11.41 $1.19 Million - $2.23 Million	195,600 New	195,600 $1.24 Million
Q4 2021 Feb 14, 2022	SELL	$17.36 - $27.36 $840,224 - $1.32 Million	-48,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$22.34 - $39.1 $1.08 Million - $1.89 Million	48,400 New	48,400 $1.1 Million

21.3M

30.7K

18.6K

Ticker SGHT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,826,200
Market Cap $311M
Description
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.